MedTrace Logo

Clinical Outcome of Pericardial Closure Using Gentrix Following Cardiac Surgery

NCT06136182 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 489

Last updated 2026-05-01

No results posted yet for this study

Summary

A descriptive comparative project will be conducted to determine if there is a difference in outcomes for adult patients requiring pericardial reconstruction using CorMatrix compared to Gentrix

Conditions

  • Clinical Outcome of Pericardial Closure Using Gentrix

Interventions

PROCEDURE

Pericardial Closure Using Gentrix Following Cardiac Surgery

To determine feasibility and effectiveness of Gentrix for cardiac use, and if this product is patient population specific.

Sponsors & Collaborators

  • Methodist Health System

    lead OTHER

Principal Investigators

  • Darien Bradford, MD · Methodist Health System

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-12
Primary Completion
2026-04-08
Completion
2026-04-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06136182 on ClinicalTrials.gov